Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.09M | -9.20M | -10.20M | -8.82M | -10.34M |
| Total Depreciation and Amortization | 32.00K | 32.00K | 32.00K | 33.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 834.00K | 1.25M | 674.00K | 423.00K | 511.00K |
| Change in Net Operating Assets | -8.72M | -7.22M | -7.27M | -15.08M | 9.39M |
| Cash from Operations | 14.24M | -15.13M | -16.76M | -23.44M | -407.00K |
| Capital Expenditure | -24.00K | -42.00K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.25M | -158.23M | 16.99M | 6.59M | -6.70M |
| Cash from Investing | 21.22M | -158.27M | 16.99M | 6.59M | -6.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 456.00K | 171.93M | 357.00K | 1.92M | 17.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 456.00K | 171.93M | 357.00K | 1.92M | 17.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.92M | -1.47M | 593.00K | -14.93M | 9.89M |